Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC

por Tegethoff, Jana, Bischoff, Roland, Saleh, Sawsan, Blagojevic, Biljana, Merz, Karl-Heinz, Cheng, Xinlai
Publicado 2017